PETER G. TRABER - 04 Jan 2023 Form 4 Insider Report for SELECTA BIOSCIENCES INC (RNAC)

Role
Chief Medical Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Peter G. Traber
Issuer symbol
RNAC
Transactions as of
04 Jan 2023
Net transactions value
-$13,185
Form type
4
Filing time
06 Jan 2023, 16:15:28 UTC
Previous filing
04 Jan 2023
Next filing
26 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SELB Common Stock Sale $9,256 -8,164 -1.8% $1.13 449,601 04 Jan 2023 Direct F1
transaction SELB Common Stock Sale $17.13 -15 -0% $1.14 449,586 04 Jan 2023 Direct F1
transaction SELB Common Stock Sale $3,890 -3,445 -0.77% $1.13 446,141 05 Jan 2023 Direct F1
transaction SELB Common Stock Sale $22.23 -20 -0% $1.11 446,121 05 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.